Prebiotic oligosaccharides directly modulate proinflammatory cytokine production in monocytes via activation of TLR4

Molecular Nutrition and Food Research

Volumn 58, Issue 5, 2014, Pages 1098-1110

  Capitán Cañadas, Fermín ^a   Ortega González, Mercedes ^a   Guadix, Emilia ^b   Zarzuelo, Antonio ^a   Suárez, María Dolores ^a   de Medina, Fermín Sánchez ^a   Martínez Augustin, Olga ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

Fructooligosaccharides; Inulin; Monocyte; NF B; Toll like receptor 4

Indexed keywords

3-(4-METHYLPHENYLSULFONYL)-2-PROPENENITRILE; GAMMA INTERFERON; IDOLAX; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; INULIN; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; NITRILE; OLIGOSACCHARIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PREBIOTIC AGENT; SULFONE; TLR4 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; FEMALE; HUMAN; MALE; METABOLISM; MONOCYTE; MOUSE; NORMAL HUMAN; RAT; SPLEEN; T LYMPHOCYTE; WISTAR RAT; YOUNG ADULT;

ADULT; ANIMALS; CELL SURVIVAL; FEMALE; HEALTHY VOLUNTEERS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; INULIN; LIPOPOLYSACCHARIDES; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MONOCYTES; NF-KAPPA B; NITRILES; OLIGOSACCHARIDES; PHOSPHATIDYLINOSITOL 3-KINASE; PREBIOTICS; RATS; RATS, WISTAR; SPLEEN; SULFONES; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84898936102     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201300497     Document Type: Article

References (39)

1. Martinez Augustin, O., Martinez de Victoria Munoz, E., Proteins and peptides in enteral nutrition. Nutr. Hosp. 2006, 21(Suppl 2), 1-13, 11-14.
2. Arvanitoyannis, I. S., Van Houwelingen-Koukaliaroglou, M., Functional foods: a survey of health claims, pros and cons, and current legislation. Crit. Rev. Food Sci. Nutr. 2005, 45, 385-404.
3. Roberfroid, M., Gibson, G. R., Hoyles, L., McCartney, A. L. et al., Prebiotic effects: metabolic and health benefits. Br. J. Nutr. 2010, 104(Suppl 2), S1-S63.
4. Macfarlane, S., Macfarlane, G. T., Cummings, J. H., Review article: prebiotics in the gastrointestinal tract. Aliment. Pharmacol. Ther. 2006, 24, 701-714.
5. Swennen, K., Courtin, C. M., Delcour, J. A., Non-digestible oligosaccharides with prebiotic properties. Crit. Rev. Food Sci. Nutr. 2006, 46, 459-471.
6. Roberfroid, M. B., Introducing inulin-type fructans. Br. J. Nutr. 2005, 93(Suppl 1), S13-S25.
7. de Vrese, M., Marteau, P. R., Probiotics and prebiotics: effects on diarrhea. J. Nutr. 2007, 137, 803S-811S.
8. Leenen, C. H., Dieleman, L. A., Inulin and oligofructose in chronic inflammatory bowel disease. J. Nutr. 2007, 137, 2572S-2575S.
9. Guarner, F., Studies with inulin-type fructans on intestinal infections, permeability, and inflammation. J. Nutr. 2007, 137, 2568S-2571S.
10. Arribas, B., Rodriguez-Cabezas, M. E., Comalada, M., Bailon, E. et al., Evaluation of the preventative effects exerted by Lactobacillus fermentum in an experimental model of septic shock induced in mice. Br. J. Nutr. 2009, 101, 51-58.
11. Baumgart, D. C., Sandborn, W. J., Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007, 369, 1641-1657.
12. Butel, M. J., Waligora-Dupriet, A. J., Szylit, O., Oligofructose and experimental model of neonatal necrotising enterocolitis. Br. J. Nutr. 2002, 87(Suppl 2), S213-S219.
13. Besselink, M. G., van Santvoort, H. C., Buskens, E., Boermeester, M. A. et al., Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 2008, 371, 651-659.
14. Shoaf, K., Mulvey, G. L., Armstrong, G. D., Hutkins, R. W., Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells. Infect. Immun. 2006, 74, 6920-6928.
15. Zenhom, M., Hyder, A., de Vrese, M., Heller, K. J. et al., Prebiotic oligosaccharides reduce proinflammatory cytokines in intestinal Caco-2 cells via activation of PPARgamma and peptidoglycan recognition protein 3. J. Nutr. 2011, 141, 971-977.
16. Eiwegger, T., Stahl, B., Haidl, P., Schmitt, J. et al., Prebiotic oligosaccharides: in vitro evidence for gastrointestinal epithelial transfer and immunomodulatory properties. Pediatr. Allergy Immunol. 2010, 21, 1179-1188.
17. Niness, K. R., Inulin and oligofructose: what are they? J. Nutr. 1999, 129, 1402S-1406S.
18. Roberfroid, M. B., Inulin-type fructans: functional food ingredients. J. Nutr. 2007, 137, 2493S-2502S.
19. Gosling, A., Stevens, G. W., Barber, A. R., Kentish, S. E. et al., Recent advances refining galactooligosaccharide production from lactose. Food Chem. 2010, 121, 307-318.
20. Chichlowski, M., German, J. B., Lebrilla, C. B., Mills, D. A., The influence of milk oligosaccharides on microbiota of infants: opportunities for formulas. Annu. Rev. Food Sci. Technol. 2011, 2, 331-351.
21. Martinez-Ferez, A., Rudloff, S., Guadix, A., Henkel, C. A. et al., Goat's milk as a natural source of lactose-derived oligosaccharides: Isolation by membrane technology. Int. Dairy J. 2006, 16, 173-181.
22. Ortega-González, M., Ocón, B., Romero-Calvo, I., Anzola, A. et al., Non-digestible oligosaccharides exert non-prebiotic effects on intestinal epithelial cells enhancing the immune response via activation of TLR4-NFκB. Mol. Nutr. Food Res. 2014, 58, 384-393.
23. Requena, P., Daddaoua, A., Guadix, E., Zarzuelo, A. et al., Bovine glycomacropeptide induces cytokine production in human monocytes through the stimulation of the MAPK and the NF-kappaB signal transduction pathways. Br. J. Pharmacol. 2009, 157, 1232-1240.
24. Ehrchen, J. M., Sunderkotter, C., Foell, D., Vogl, T. et al., The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J. Leukoc. Biol. 2009, 86, 557-566.
25. Piccinini, A. M., Midwood, K. S., DAMPening inflammation by modulating TLR signalling. Mediators Inflamm. 2010, 2010, 672395.
26. Zenhom, M., Hyder, A., de Vrese, M., Heller, K. J. et al., Prebiotic oligosaccharides reduce proinflammatory cytokines in intestinal Caco-2 cells via activation of PPARgamma and peptidoglycan recognition protein 3. J. Nutr. 2011, 141, 971-977.
27. de Kivit, S., van Hoffen, E., Korthagen, N., Garssen, J. et al., Apical TLR ligation of intestinal epithelial cells drives a Th1-polarized regulatory or inflammatory type effector response in vitro. Immunobiology 2011, 216, 518-527.
28. Eiwegger, T., Stahl, B., Schmitt, J., Boehm, G. et al., Human milk-derived oligosaccharides and plant-derived oligosaccharides stimulate cytokine production of cord blood T-cells in vitro. Pediatr. Res. 2004, 56, 536-540.
29. Kunz, C., Rodriguez-Palmero, M., Koletzko, B., Jensen, R., Nutritional and biochemical properties of human milk, Part I: general aspects, proteins, and carbohydrates. Clin. Perinatol. 1999, 26, 307-333.
30. Kuntz, S., Rudloff, S., Kunz, C., Oligosaccharides from human milk influence growth-related characteristics of intestinally transformed and non-transformed intestinal cells. Br. J. Nutr. 2008, 99, 462-471.
31. Lane, J. A., O'Callaghan, J., Carrington, S. D., Hickey, R. M., Transcriptional response of HT-29 intestinal epithelial cells to human and bovine milk oligosaccharides. Br. J. Nutr. 2013, 1-11, DOI: 10.1017/S0007114513001591
32. Daddaoua, A., Martinez-Plata, E., Lopez-Posadas, R., Vieites, J. M. et al., Active hexose correlated compound acts as a prebiotic and is antiinflammatory in rats with hapten-induced colitis. J. Nutr. 2007, 137, 1222-1228.
33. Daddaoua, A., Puerta, V., Requena, P., Martinez-Ferez, A. et al., Goat milk oligosaccharides are anti-inflammatory in rats with hapten-induced colitis. J. Nutr. 2006, 136, 672-676.
34. Damaskos, D., Kolios, G., Probiotics and prebiotics in inflammatory bowel disease: microflora 'on the scope'. Br. J. Clin. Pharmacol. 2008, 65, 453-467.
35. Sainathan, S. K., Hanna, E. M., Gong, Q., Bishnupuri, K. S. et al., Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis. Inflamm. Bowel Dis. 2008, 14, 88-99.
36. Xu, Y., Hunt, N. H., Bao, S., The role of granulocyte macrophage-colony-stimulating factor in acute intestinal inflammation. Cell Res. 2008, 18, 1220-1229.
37. Shea-Donohue, T., Thomas, K., Cody, M. J., Aiping, Z. et al., Mice deficient in the CXCR2 ligand, CXCL1 (KC/GRO-alpha), exhibit increased susceptibility to dextran sodium sulfate (DSS)-induced colitis. Innate Immun. 2008, 14, 117-124.
38. Kuhl, A. A., Kakirman, H., Janotta, M., Dreher, S. et al., Aggravation of different types of experimental colitis by depletion or adhesion blockade of neutrophils. Gastroenterology 2007, 133, 1882-1892.
39. Sánchez de Medina, F., Daddaoua, A., Requena, P., Capitán-Cañadas, F. et al., New insights into the immunological effects of food bioactive peptides in animal models of intestinal inflammation. Proc. Nutr. Soc. 2010, 69, 454-462.